Skip to Content
Merck
  • Ferroquine, the next generation antimalarial drug, has antitumor activity.

Ferroquine, the next generation antimalarial drug, has antitumor activity.

Scientific reports (2017-11-23)
Artem Kondratskyi, Kateryna Kondratska, Fabien Vanden Abeele, Dmitri Gordienko, Charlotte Dubois, Robert-Allain Toillon, Christian Slomianny, Sébastien Lemière, Philippe Delcourt, Etienne Dewailly, Roman Skryma, Christophe Biot, Natalia Prevarskaya
ABSTRACT

Despite the tremendous progress in medicine, cancer remains one of the most serious global health problems awaiting new effective therapies. Here we present ferroquine (FQ), the next generation antimalarial drug, as a promising candidate for repositioning as cancer therapeutics. We report that FQ potently inhibits autophagy, perturbs lysosomal function and impairs prostate tumor growth in vivo. We demonstrate that FQ negatively regulates Akt kinase and hypoxia-inducible factor-1α (HIF-1α) and is particularly effective in starved and hypoxic conditions frequently observed in advanced solid cancers. FQ enhances the anticancer activity of several chemotherapeutics suggesting its potential application as an adjuvant to existing anticancer therapy. Alike its parent compound chloroquine (CQ), FQ accumulates within and deacidifies lysosomes. Further, FQ induces lysosomal membrane permeabilization, mitochondrial depolarization and caspase-independent cancer cell death. Overall, our work identifies ferroquine as a promising new drug with a potent anticancer activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Fluorescein isothiocyanate–dextran, average mol wt 10,000
Sigma-Aldrich
Acridine Orange hydrochloride solution, ≥95.0% (HPLC), 10 mg/mL in H2O
Sigma-Aldrich
Anti-LC3B antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Ferrocene, 98%
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Ferroquine, ≥98% (HPLC)
Sigma-Aldrich
Ferrostatin-1, ≥95% (HPLC)
Roche
Cytotoxicity Detection Kit (LDH), suitable for protein quantification, suitable for cell analysis, detection, sufficient for ≤2,000 tests